174 related articles for article (PubMed ID: 27576135)
21. ADAM17-Mediated Ectodomain Shedding of Toll-Like Receptor 4 as a Negative Feedback Regulation in Lipopolysaccharide-Activated Aortic Endothelial Cells.
Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
Cell Physiol Biochem; 2018; 45(5):1851-1862. PubMed ID: 29510400
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract][Full Text] [Related]
23. Structural Aspects of N-Glycosylations and the C-terminal Region in Human Glypican-1.
Awad W; Adamczyk B; Örnros J; Karlsson NG; Mani K; Logan DT
J Biol Chem; 2015 Sep; 290(38):22991-3008. PubMed ID: 26203194
[TBL] [Abstract][Full Text] [Related]
24. The metalloprotease ADAM17 in inflammation and cancer.
Düsterhöft S; Lokau J; Garbers C
Pathol Res Pract; 2019 Jun; 215(6):152410. PubMed ID: 30992230
[TBL] [Abstract][Full Text] [Related]
25. ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses.
Yan I; Schwarz J; Lücke K; Schumacher N; Schumacher V; Schmidt S; Rabe B; Saftig P; Donners M; Rose-John S; Mittrücker HW; Chalaris A
J Leukoc Biol; 2016 May; 99(5):749-60. PubMed ID: 26561568
[TBL] [Abstract][Full Text] [Related]
26. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.
Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M
Elife; 2018 Jun; 7():. PubMed ID: 29897336
[TBL] [Abstract][Full Text] [Related]
27. ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin.
Malapeira J; Esselens C; Bech-Serra JJ; Canals F; Arribas J
Oncogene; 2011 Apr; 30(16):1912-22. PubMed ID: 21170088
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE.
Cavadas M; Oikonomidi I; Gaspar CJ; Burbridge E; Badenes M; Félix I; Bolado A; Hu T; Bileck A; Gerner C; Domingos PM; von Kriegsheim A; Adrain C
Cell Rep; 2017 Oct; 21(3):745-757. PubMed ID: 29045841
[TBL] [Abstract][Full Text] [Related]
29. Disruption of TACE-filamin interaction can inhibit TACE-mediated ectodomain shedding.
Cho Y; Park D; Kim C
Biochem Biophys Res Commun; 2017 Aug; 490(3):997-1003. PubMed ID: 28666872
[TBL] [Abstract][Full Text] [Related]
30. Proteomic Investigation of Differential Interactomes of Glypican 1 and a Putative Disease-Modifying Variant of Ataxia.
Cengiz Winter N; Karakaya M; Mosen P; Brusius I; Anlar B; Haliloglu G; Winter D; Wirth B
J Proteome Res; 2023 Sep; 22(9):3081-3095. PubMed ID: 37585105
[TBL] [Abstract][Full Text] [Related]
31. Ectodomain shedding by ADAM17 (a disintegrin and metalloproteinase 17) in canine neutrophils.
Snyder KM; McAloney CA; Montel JS; Modiano JF; Walcheck B
Vet Immunol Immunopathol; 2021 Jan; 231():110162. PubMed ID: 33264689
[TBL] [Abstract][Full Text] [Related]
32. ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
Schumacher N; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119141. PubMed ID: 34610348
[TBL] [Abstract][Full Text] [Related]
33. Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis.
Li X; Maretzky T; Perez-Aguilar JM; Monette S; Weskamp G; Le Gall S; Beutler B; Weinstein H; Blobel CP
J Cell Sci; 2017 Mar; 130(5):868-878. PubMed ID: 28104813
[TBL] [Abstract][Full Text] [Related]
34. Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17.
Zhao Y; Dávila EM; Li X; Tang B; Rabinowitsch AI; Perez-Aguilar JM; Blobel CP
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361585
[TBL] [Abstract][Full Text] [Related]
35. Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17.
Dolla G; Nicolas S; Dos Santos LR; Bourgeois A; Pardossi-Piquard R; Bihl F; Zaghrini C; Justino J; Payré C; Mansuelle P; Garbers C; Ronco P; Checler F; Lambeau G; Petit-Paitel A
J Biol Chem; 2024 Jun; ():107480. PubMed ID: 38897568
[TBL] [Abstract][Full Text] [Related]
36. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
37. iRhom2 regulates ectodomain shedding and surface expression of the major histocompatibility complex (MHC) class I.
Calligaris M; Spanò DP; Bonelli S; Müller SA; Carcione C; D'apolito D; Amico G; Miele M; Di Bella M; Zito G; Nuti E; Rossello A; Blobel CP; Lichtenthaler SF; Scilabra SD
Cell Mol Life Sci; 2024 Apr; 81(1):163. PubMed ID: 38570362
[TBL] [Abstract][Full Text] [Related]
38. Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes.
Qiao D; Meyer K; Friedl A
Mol Cell Biol; 2013 Nov; 33(22):4408-21. PubMed ID: 24019070
[TBL] [Abstract][Full Text] [Related]
39. HPP1 Ectodomain Shedding is Mediated by ADAM17 and is Necessary for Tumor Suppression in Colon Cancer.
Elahi A; Ajidahun A; Hendrick L; Getun I; Humphries LA; Hernandez J; Shibata D
J Surg Res; 2020 Oct; 254():183-190. PubMed ID: 32450419
[TBL] [Abstract][Full Text] [Related]
40. ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation.
Lajoie L; Congy-Jolivet N; Bolzec A; Gouilleux-Gruart V; Sicard E; Sung HC; Peiretti F; Moreau T; Vié H; Clémenceau B; Thibault G
J Immunol; 2014 Jan; 192(2):741-51. PubMed ID: 24337742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
